Pathogenesis of myeloma bone disease

被引:278
|
作者
Roodman, G. D. [1 ]
机构
[1] Univ Pittsburgh, Vet Affairs Pittsburgh Healthcare Syst, Dept Med Hematol Oncol, Sch Med, Pittsburgh, PA 15240 USA
关键词
multiple myeloma; osteoclast; osteoblast; bone disease; KAPPA-B LIGAND; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR-NECROSIS-FACTOR; MULTIPLE-MYELOMA; RECEPTOR ACTIVATOR; IN-VIVO; INHIBITS OSTEOCLASTOGENESIS; OSTEOBLAST DIFFERENTIATION; MARROW MICROENVIRONMENT; PROTEASOME INHIBITOR;
D O I
10.1038/leu.2008.336
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bone disease in multiple myeloma (MM) is characterized by lytic bone lesions, which can cause severe bone pain, pathologic fractures and hypercalcemia. However, the lytic bone disease in MM differs from that in other cancer patients who have lytic bone metastases. Although increased osteoclastic bone destruction is involved in MM and other tumors involving bone, in contrast to other tumors, once the MM tumor burden exceeds 50% in a local area, osteoblast activity is either suppressed or absent. 1 The basis for this severe imbalance between increased osteoclastic bone resorption and decreased bone formation has been a topic of intensive investigation over the last several years and will be reviewed in this article.
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [31] Myeloma bone disease
    Mundy, GR
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (02) : 246 - 251
  • [32] Assessment of the role of IL-1 beta in the pathogenesis of myeloma bone disease.
    Alsina, M
    Choi, SJ
    Devlin, RD
    Cruz, JC
    Roodman, GD
    BLOOD, 1997, 90 (10) : 2346 - 2346
  • [33] Myeloma-bone interaction for the development of myeloma bone disease
    Matsumoto, T
    Kido, S
    Inoue, D
    Oshima, T
    Abe, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1566 - 1566
  • [34] The role of the bone marrow microenvironment in the pathogenesis of multiple myeloma
    Jurczyszyn, Artur
    Gdula-Argasinska, Joanna
    Kosmaczewska, Agata
    Skotnicki, Aleksander B.
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 : 521 - 533
  • [35] Pathophysiology of myeloma bone disease
    Esteve, Flavia R.
    Roodman, G. David
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 613 - 624
  • [36] Myeloma bone disease.
    Mundy, GR
    Oyajobi, B
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) : 819 - 819
  • [37] Bone disease in multiple myeloma
    Croucher, PI
    Apperley, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) : 902 - 910
  • [38] Pathophysiology of myeloma bone disease
    Croucher, P. I.
    Heath, D.
    Chantry, A.
    Lawson, M.
    Buckle, C.
    Vanderkerken, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 17 - 18
  • [39] Bone Disease in Multiple Myeloma
    Drake, Matthew T.
    ONCOLOGY-NEW YORK, 2009, 23 (14): : 28 - 32
  • [40] Myeloma, bone, and disease control
    Epstein, J.
    CANCER TREATMENT REVIEWS, 2006, 32 : S23 - S23